666

HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION

No trades
See on Supercharts
Market capitalization
‪3.61 B‬CNY
‪292.16 M‬CNY
‪10.36 B‬CNY
‪112.93 M‬
Beta (1Y)
1.14

About HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION

CEO
Wei Dong Zhu
Headquarters
Harbin
Employees (FY)
‪2.96 K‬
Founded
1993
ISIN
CNE000000G05
FIGI
BBG000BKCX42
HPGC Renmintongtai Pharmaceutical Corp. engages in the operation of pharmaceutical business. Its businesses include wholesale and retail of pharmaceutical products, logistics, e-commerce, and operation of hospitals. It sells medical equipment, health products, daily necessities, and chemical reagents. The company was founded on August 15, 1993 and is headquartered in Harbin, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 600829 is 6.17 CNY — it has decreased by 0.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION stocks are traded under the ticker 600829.
600829 stock is 2.79% volatile and has beta coefficient of 1.14. Check out the list of the most volatile stocks — is HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION there?
Yes, you can track HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION financials in yearly and quarterly reports right on TradingView.
600829 stock has fallen by 7.08% compared to the previous week, the month change is a 8.59% fall, over the last year HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION has showed a 5.66% decrease.
600829 net income for the last quarter is ‪51.62 M‬ CNY, while the quarter before that showed ‪87.20 M‬ CNY of net income which accounts for −40.80% change. Track more HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION financial stats to get the full picture.
Today HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION has the market capitalization of ‪3.61 B‬, it has decreased by 2.37% over the last week.
HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION dividend yield was 1.84% in 2023, and payout ratio reached 28.58%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 600829 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
600829 reached its all-time high on Jun 18, 2015 with the price of 29.00 CNY, and its all-time low was 3.81 CNY and was reached on Sep 7, 2005.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪2.96 K‬ employees. See our rating of the largest employees — is HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION stock shows the sell signal. See more of HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION EBITDA is ‪473.34 M‬ CNY, and current EBITDA margin is 4.58%. See more stats in HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION financial statements.